4//SEC Filing
Niihara Yutaka 4
Accession 0001209191-22-053757
CIK 0000822370other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 1:01 PM ET
Size
9.0 KB
Accession
0001209191-22-053757
Insider Transaction Report
Form 4
Niihara Yutaka
DirectorChairman and CEO10% Owner
Transactions
- Purchase
Common stock, $0.001 par value
2022-10-13$0.18/sh+62,500$11,250→ 11,746,357 total - Purchase
Common stock, $0.001 par value
2022-10-14$0.17/sh+35,000$5,950→ 11,781,357 total
Holdings
- 63,000(indirect: By Soomi Niihara)
Common stock, $0.001 par value
- 92,794(indirect: By Hope International Hospice, Inc.)
Common stock, $0.001 par value
Footnotes (4)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.10 to $0.31, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4.
- [F2]The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.
- [F3]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.15 to $0.18, inclusive.
- [F4]Hope International Hospice, Inc. is a California corporation of which Dr. Niihara and his wife are the sole shareholders and directors.
Documents
Issuer
Emmaus Life Sciences, Inc.
CIK 0000822370
Entity typeother
Related Parties
1- filerCIK 0001517691
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 1:01 PM ET
- Size
- 9.0 KB